|
ADD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.8158033116863E-11 |
| Normal-vs-Stage3 |
2.85079737594174E-11 |
| Normal-vs-Stage4 |
8.74799999994735E-07 |
| Stage1-vs-Stage2 |
7.715000E-01 |
| Stage1-vs-Stage3 |
5.598000E-01 |
| Stage1-vs-Stage4 |
6.035800E-01 |
| Stage2-vs-Stage3 |
4.436800E-01 |
| Stage2-vs-Stage4 |
4.083600E-01 |
| Stage3-vs-Stage4 |
8.704000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.59712259978551E-14 |
| Normal-vs-Asian |
5.68819999999803E-05 |
| Caucasian-vs-AfricanAmerican |
3.486400E-01 |
| Caucasian-vs-Asian |
9.373400E-01 |
| AfricanAmerican-vs-Asian |
8.115200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.3628655415896E-13 |
| Normal-vs-Female |
1.31849975382181E-10 |
| Male-vs-Female |
1.126340E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.36064509554035E-12 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
2.76134670684769E-12 |
| Normal-vs-Extreme_Obese |
3.18759463269203E-11 |
| Normal_Weight-vs-Extreme_Weight |
5.208200E-01 |
| Normal_Weight-vs-Obese |
4.928200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.514000E-01 |
| Extreme_Weight-vs-Obese |
7.579500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.155800E-01 |
| Obese-vs-Extreme_Obese |
2.513800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.63890037494252E-11 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.77079999552632E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.643000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.129210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.890400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.226300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.075600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.447000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.81787918052123E-12 |
| Normal-VS-Type2 PRCC |
4.85256279603163E-12 |
| Normal-VS-KIRP CIMP |
3.38950000000615E-06 |
| Normal-VS-Unclassified PRCC |
1.00650043854955E-10 |
| Type1 PRCC-VS-Type2 PRCC |
4.127500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.790500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.509400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.725800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.454200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.359600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.21964677141295E-15 |
| Normal-vs-N1 |
5.17469955774175E-10 |
| Normal-vs-N2 |
5.977000E-04 |
| N0-vs-N1 |
3.036600E-01 |
| N0-vs-N2 |
9.281600E-01 |
| N1-vs-N2 |
6.644400E-01 |
|
|
